PALB2 variants in hereditary and unselected Finnish Prostate cancer cases

Background PALB2 1592delT mutation is associated with increased breast cancer and suggestive prostate cancer (PRCA) risk in Finland. In this study we wanted to assess if any other PALB2 variants associate to increased PRCA risk and clinically describe patients with formerly found PALB2 1592delT mutation.Methods Finnish families with two or more PRCA cases (n=178) and unselected cases (n=285) with complete clinical data were initially screened for variants in the coding region and splice sites of PALB2.

Potentially interesting variants were verified in additional set of unselected cases (n=463).Results From our clinically defined sample set we identified total of six variants in PALB2. No novel variants among Finnish PRCA cases were found.

Clinical characteristics of the variant carriers, including the previously described family carrying PALB2 1592delT, revealed a trend towards aggressive disease, which also applied to a few non-familial cases. Hypersensitivity to mitomycin C (MMC) of lymphoblasts from individuals from the family with 1592delT revealed haploinsufficiency among carriers with altered genotype.Conclusions Though any of the detected PALB2 variants do not associate to PRCA in population level in Finland it cannot be ruled out that some of these variants contribute to cancer susceptibility at individual level.

Author: Sanna PakkanenTiina WahlforsSanna SiltanenMimmi PatrikainenMika MatikainenTeuvo TammelaJohanna Schleutker
Credits/Source: Journal of Negative Results in BioMedicine 2009, 8:12

Published on: 2009-12-15

Copyright by the authors listed above - made available via BioMedCentral (Open Access). Please make sure to read our disclaimer prior to contacting 7thSpace Interactive. To contact our editors, visit our online helpdesk. If you wish submit your own press release, click here.

Comments Page 0 of 0

There are currently 0 comments to display.

+ Add New Comment

Custom Search